Iradimed (IRMD) Income towards Parent Company (2016 - 2025)
Historic Income towards Parent Company for Iradimed (IRMD) over the last 13 years, with Q3 2025 value amounting to $5.6 million.
- Iradimed's Income towards Parent Company rose 1043.99% to $5.6 million in Q3 2025 from the same period last year, while for Sep 2025 it was $20.5 million, marking a year-over-year increase of 1907.69%. This contributed to the annual value of $18.5 million for FY2024, which is 1753.58% up from last year.
- According to the latest figures from Q3 2025, Iradimed's Income towards Parent Company is $5.6 million, which was up 1043.99% from $5.8 million recorded in Q2 2025.
- Iradimed's 5-year Income towards Parent Company high stood at $5.8 million for Q2 2025, and its period low was $1.4 million during Q1 2021.
- In the last 5 years, Iradimed's Income towards Parent Company had a median value of $3.9 million in 2021 and averaged $3.8 million.
- Over the last 5 years, Iradimed's Income towards Parent Company had its largest YoY gain of 27919.82% in 2021, and its largest YoY loss of 2161.2% in 2021.
- Over the past 5 years, Iradimed's Income towards Parent Company (Quarter) stood at $3.9 million in 2021, then fell by 5.63% to $3.7 million in 2022, then fell by 15.13% to $3.1 million in 2023, then soared by 42.7% to $4.4 million in 2024, then rose by 25.34% to $5.6 million in 2025.
- Its Income towards Parent Company was $5.6 million in Q3 2025, compared to $5.8 million in Q2 2025 and $4.7 million in Q1 2025.